discussing the phase ii study of lenvatinib/pembrolizumab in metastatic ccrcc
Published 4 years ago • 485 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
0:47
phase 2 trial shows antitumor activity in metastatic clear cell rcc
-
3:15
phase ii study of petosemtamab and pembrolizumab for recurrent/metastatic hnscc
-
4:28
metastatic renal cell carcinoma: lenvatinib phase ii data
-
32:46
lenvatinib pembrolizumab in rcc, the clear trial with karine tawagi
-
2:37
lenvatinib/everolimus in refractory mrcc
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
1:56
exploring medi0680/durvalumab versus nivolumab in metastatic ccrcc
-
2:32
len pembro metastatic clear cell renal cell carcinoma
-
1:32
phase 2 trial of lenvatinib and everolimus in metastatic renal cell carcinoma
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
3:01
a phase iii trial of pembrolizumab as adjuvant treatment for renal cell carcinoma
-
1:19
phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
0:57
the role of lenvatinib in nsclc treatment
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
1:29
phase i/ii study of nivolumab and axitinib for advanced rcc
-
2:40
efficacy and safety of lenvatinib/everolimus in mrcc
-
29:11
new data and clinical context: an update on renal cell carcinoma care
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc
-
2:45
final keynote-048 results with frontline pembrolizumab in recurrent/metastatic hnscc